Ars Technica reports that the FDA wants to withdraw its approval of the drug Tavneos, but doing so is not easy.
The regulator says the drug was approved on the basis of manipulated study data. The article asks whether patients should still have access to it.
Source: arstechnica.com, reported 10-31. https://arstechnica.com/science/2026/10/the-fda-wants-to-pull-its-approval-of-a-drug-its-not-so-easy/